Abstract
In routine clinical phototesting and in basic research, naked eye dermatological assessment is the “gold standard” for determining the patient’s minimal erythemal dose (MED). In UV-B testing with a divergent, radially attenuating beam of characterised dosimetry, laser Doppler perfusion imaging has been previously used to give quantitative description of reactivity to doses above the MED in addition to a “single-dose” objective determination of the MED itself. In the present paper, the recently developed tissue viability imaging (TiVi) technology is presented for the first time as a reliable, easily applicable, high-resolution alternative to LDPI in the divergent beam testing concept. Data obtained after provocation with a range of doses was analysed in order to determine the reaction diameter, which can be related to the MED using field dosimetry. The dose–response features of exposure above the MED and the relationship between naked eye readings and the diameter were determined from the image data. TiVi data were obtained faster than LDPI data and at a higher spatial resolution of 100 μm instead of 1 mm. A tool was developed to centre over the erythema area of the acquired image. Response data could be plotted continuously against dose. Thresholding of processed images compared to naked eye “gold standard” readings showed that the normal skin value +4 standard deviations produced a good fit between both methods. A linear fitting method for the dose–response data provided a further method of determination of the reaction diameter (MED). Erythemal “volume under the surface (VUS)” for the reaction provided a new concept for visualising information. TiVi offers advantages over LDPI in the acquisition and analysis of data collected during divergent beam testing. An increased amount of data compared to traditional phototesting is easily and more objectively obtained which increases applicability in the clinical and research environment.
Similar content being viewed by others
References
Ananthaswamy HN, Loughlin S, Cox P, Evans RL, Ullrich SE, Kripke ML (1997) Sunlight and skin cancer: inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens. Nat Med 3:510–514
Dawe RS, Cameron H, Yule S, Man I, Ibbotson SH, Ferguson J (2002) UV-B phototherapy clears psoriasis through local effects. Arch Dermatol 138:1071–1076
Falk M (2007) Towards a broader use of phototesting. PhD thesis, Linköping University, Sweden
Falk M, Ilias MA, Wårdell K, Anderson C (2003) Phototesting with a divergent UV-B beam in the investigation of anti-inflammatory effects of topically applied substances. Photodermatol Photo 19:195–202
Falk M, Ilias M, Anderson C (2008) Inter-observer variability in reading of phototest reactions with sharply or diffusely delineated borders. Skin Res Technol 14:397–402
Falk M, Anderson C (2010) Reliability of self-assessed reading of skin tests—a possible approach in research and clinical practice? Dermatol Online J 16(2):4
Falk M, Anderson C (2008) Prevention of skin cancer in primary healthcare: an evaluation of three different prevention effort levels and the applicability of a phototest. Eur J Gen Pract 14:68–75
Farage M (2008) Enhancement of visual scoring of skin irritant reactions using cross-polarized light and parallel-polarized light. Contact Dermatitis 58:147–155
Fitzpatrick TB (1988) The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124(6):869–871
Gordon PM, Saunders PJ, Diffey BL, Farr PM (1998) Phototesting prior to narrowband (TL-01) ultraviolet B phototherapy. Br J Dermatol 139(5):811–814
Hamzavi I (2006) Photoadaptation: a path toward rational phototherapy protocols. J Invest Dermatol 126:2156–2158
Henricson J, Nilsson A, Tesselaar E, Nilsson G, Sjöberg F (2009) Tissue viability imaging: microvascular response to vasoactive drugs induced by iontophoresis. Microvasc Res 78(2):199–205
Ilias MA, Anderson C, Wårdell K (1999) Single exposure phototesting utilizing a divergent ultraviolet beam. Skin Res Tech 5:255–259
Ilias MA, Wårdell K, Falk M, Anderson C (2001) Phototesting based on a divergent beam—a study on normal subjects. Photodermatol Photo 17:189–196
Ilias MA (2004) Single exposure phototesting and assessment of pigmented skin lesions—quantitative methods in terms of blood perfusion estimates, PhD thesis, Linköping University, Sweden
Leahy MJ, Enfield JG, Clancy NT, O’Doherty J, McNamara P, Nilsson GE (2007) Biophotonic methods in microcirculation imaging. Med Laser Appl 22:105–126
Leahy MJ, de Mul FFM, Nilsson GE, Maniewski R (1999) Principles and practices of the laser Doppler perfusion technique. Technol Health Care 7:143–162
Mallbris L, Edstrom DW, Sunblad L, Granath F, Ståhle M (2005) UVB up-regulates the antimicrobial protein hCAP18 mRNA in human skin. J Invest Dermatol 125:1072–1074
McNamara P, O’Doherty J, O’Connell ML, Fitzgerald BW, Anderson C, Nilsson GE, Toll RJ, Leahy MJ (2009) Tissue viability (TiVi) imaging: temporal effects of local occlusion studies in the volar forearm. J Biophotonics 3:66–74
Millard TP, Hawk JL (2002) Photosensitivity disorders: cause, effect and management. Am J Clin Dermatol 3:239–246
Moseley H, Naasan H, Dawe RS, Woods J, Ferguson J (2008) Population reference intervals for minimal erythemal doses in monochromator phototesting. Photoderm Photoimmunol Photomed 25:8–11
Nilsson GE, Zhai H, Chan HP, Farahmand S, Maibach HI (2009) Cutaneous bioengineering instrumentation standardization: the tissue viability imager. Skin Res Tech 15:6–13
O’Doherty J, Henricson J, Anderson C, Leahy MJ, Nilsson GE, Sjöberg F (2007) Sub-epidermal imaging using polarized light spectroscopy for assessment of skin microcirculation. Skin Res Tech 13:472–484
O’Doherty J (2008) Assessment of tissue viability by polarised light spectroscopy, PhD thesis, University of Limerick, Ireland
O’Doherty J, McNamara P, Clancy NT, Enfield JG, Leahy MJ (2009) Comparison of instruments of microcirculatory blood flow and red blood cell concentration. J Biomed Opt 14(3):034025
Palmer RA, Aquilina S, Milligan PJ, Walker SL, Hawk JL, Young AR (2006) Photoadaptation during narrowband ultraviolet-B therapy is independent of skin type: a study of 352 patients. J Invest Dermatol 126:1256–1263
Roelandts R, Ryckaert S (1999) Solar urticaria: the annoying photodermatosis. Int J Dermatol 38:411–418
Schornagel IJ, Sigurdsson V, Nijhuis EHJ, Bruijnzeel-Koomen CAFM, Knol EF (2004) Decreased neutrophil skin infiltration after UV-B exposure in patients with polymorphous light eruption. J Invest Dermatol 123:202–206
Urbach F (1969) Solar simulation for phototesting of human skin In: Urbach F (ed) The biologic effects of ultraviolet radiation with emphasis on the skin. Pergamon Press, NY, pp 107–114
Wirén K, Frithiof H, Sjöqvist C, Lodén M (2009) Enhancement of bioavailability by lowering of fat content in topical formulations. Br J Dermatol 160(3):552–556
Yaar M, Gilchrest BA (2007) Photoageing: mechanism, prevention, therapy. Br J Dermatol 157:874–887
Youn JI, Park JY, Jo SJ, Rim JH, Choe YB (2003) Assessment of the usefulness of skin phototype and skin color as the parameter of cutaneous narrow band UV-B sensitivity in psoriasis patients. Photodermatol Photo 19:261–264
Zasloff M (2005) Sunlight, Vitamin D, and the innate immune defenses of the human skin. J Invest Dermatol 125:xvi–xvii
Zhai H, Chan HP, Farahmand S, Nilsson GE, Maibach HI (2009) Comparison of tissue viability imaging and colorimetry: skin blanching. Skin Res Tech 15:20–23
Zhai H, Chan HP, Farahmand S, Nilsson GE, Maibach HI (2009) Tissue viability imaging: mapping skin erythema. Skin Res Tech 15:14–19
Acknowledgments
The authors acknowledge the work of the “Beam Team” Mikael Ilias, Magnus Falk, Karin Wårdell and Marcus Skogh, the dermatologist who first suggested that a radially attenuated field of provocation might provide information which was descriptive for the individual’s reactivity to ultraviolet light. Support to the divergen beam project has been given by the Medical Research Council of Southeast Sweden. The authors would like to acknowledge the support of the IRCSET (Irish Research Council for Science, Engineering & Technology) for funding this project. This research was also supported by the National Biophotonics Imaging Platform (NBIP) Ireland funded under the Higher Education Authority PRTLI Cycle 4, co-funded by the Irish Government and the European Union—Investing in your future. The authors GEN and CDA have roles in the commercialisation of the polarisation spectroscopy instrumentation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
O’Doherty, J., Henricson, J., Enfield, J. et al. Tissue viability imaging (TiVi) in the assessment of divergent beam UV-B provocation. Arch Dermatol Res 303, 79–87 (2011). https://doi.org/10.1007/s00403-010-1055-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-010-1055-2